These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 26644521

  • 1. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.
    Kerr JR.
    J Clin Pathol; 2016 Apr; 69(4):279-91. PubMed ID: 26644521
    [Abstract] [Full Text] [Related]

  • 2. Human parvovirus B19 infection and autoimmunity.
    Lunardi C, Tinazzi E, Bason C, Dolcino M, Corrocher R, Puccetti A.
    Autoimmun Rev; 2008 Dec; 8(2):116-20. PubMed ID: 18700174
    [Abstract] [Full Text] [Related]

  • 3. [Parvovirus B19 infections in adults].
    Jacquot R, Gerfaud-Valentin M, Mekki Y, Billaud G, Jamilloux Y, Sève P.
    Rev Med Interne; 2022 Dec; 43(12):713-726. PubMed ID: 36088203
    [Abstract] [Full Text] [Related]

  • 4. Parvovirus B19 infection and autoimmune disease.
    Lehmann HW, von Landenberg P, Modrow S.
    Autoimmun Rev; 2003 Jun; 2(4):218-23. PubMed ID: 12848949
    [Abstract] [Full Text] [Related]

  • 5. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties.
    Lunardi C, Tiso M, Borgato L, Nanni L, Millo R, De Sandre G, Severi AB, Puccetti A.
    Eur J Immunol; 1998 Mar; 28(3):936-48. PubMed ID: 9541589
    [Abstract] [Full Text] [Related]

  • 6. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.
    Kerr JR, Coyle PV, DeLeys RJ, Patterson CC.
    J Med Virol; 1996 Jan; 48(1):68-75. PubMed ID: 8825713
    [Abstract] [Full Text] [Related]

  • 7. Neurological manifestations of human parvovirus B19 infection.
    Barah F, Vallely PJ, Cleator GM, Kerr JR.
    Rev Med Virol; 2003 Jan; 13(3):185-99. PubMed ID: 12740833
    [Abstract] [Full Text] [Related]

  • 8. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
    Tzang BS, Lee YJ, Yang TP, Tsay GJ, Shi JY, Tsai CC, Hsu TC.
    Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
    [Abstract] [Full Text] [Related]

  • 9. [Various clinical symptoms in human parvovirus B19 infection].
    Kumano K.
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):448-53. PubMed ID: 19122375
    [Abstract] [Full Text] [Related]

  • 10. Human parvovirus B19 infection and antiphospholipid antibodies.
    von Landenberg P, Lehmann HW, Modrow S.
    Autoimmun Rev; 2007 Apr; 6(5):278-85. PubMed ID: 17412298
    [Abstract] [Full Text] [Related]

  • 11. Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.
    Thammasri K, Rauhamäki S, Wang L, Filippou A, Kivovich V, Marjomäki V, Naides SJ, Gilbert L.
    PLoS One; 2013 Apr; 8(6):e67179. PubMed ID: 23776709
    [Abstract] [Full Text] [Related]

  • 12. Rheumatic manifestations of parvovirus B19 infection.
    Naides SJ.
    Rheum Dis Clin North Am; 1998 May; 24(2):375-401. PubMed ID: 9606764
    [Abstract] [Full Text] [Related]

  • 13. Autoantibodies following parvovirus B19 infection.
    Kerr JR, Boyd N.
    J Infect; 1996 Jan; 32(1):41-7. PubMed ID: 8852550
    [Abstract] [Full Text] [Related]

  • 14. [24 cases of human parvovirus B19 infection in children].
    Borreda D, Palomera S, Gilbert B, Lienhardt A, de Lumley L.
    Ann Pediatr (Paris); 1992 Nov; 39(9):543-9. PubMed ID: 1334393
    [Abstract] [Full Text] [Related]

  • 15. Infections caused by parvovirus B19.
    Chinea B, Ramírez Ronda CH.
    Bol Asoc Med P R; 1996 Nov; 88(1-3):20-6. PubMed ID: 8885443
    [Abstract] [Full Text] [Related]

  • 16. Parvovirus B19 infection as a cause of acute myositis in an adult.
    Cakirca M, Karatoprak C, Ugurlu S, Zorlu M, Kıskaç M, Çetin G.
    Rev Bras Reumatol; 2015 Nov; 55(2):185-8. PubMed ID: 25839959
    [Abstract] [Full Text] [Related]

  • 17. [Blood picture findings in children with Parvovirus B19 infections (fifth disease/erythema infectiosum)].
    Wiersbitzky S, Schwarz TF, Ladstätter L, Bruns R, Abel E, Deinhardt F, Roggendorf M, Paul W, Jäger G, Hottenträger B.
    Kinderarztl Prax; 1991 Oct; 59(10):302-6. PubMed ID: 1660551
    [Abstract] [Full Text] [Related]

  • 18. Parvovirus B19 in human disease.
    Brown KE, Young NS.
    Annu Rev Med; 1997 Oct; 48():59-67. PubMed ID: 9046945
    [Abstract] [Full Text] [Related]

  • 19. Unscrambling the role of human parvovirus B19 signaling in systemic autoimmunity.
    Tsay GJ, Zouali M.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1453-9. PubMed ID: 16764828
    [Abstract] [Full Text] [Related]

  • 20. [Parvovirus B19 infection: the general aspects and gestational problems].
    Di Stefano L, Carta G, Barnabei R, Tomei E, Toro G, Moscarini M.
    Minerva Ginecol; 1995 Apr 30; 47(4):121-5. PubMed ID: 7644092
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.